Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer

Beclin1 and mechanistic target of rapamycin (mTOR) can be used as tumor markers of epithelial ovarian cancer. This study aimed to assess the association of Beclin1 and mTOR expression with clinicopathological and prognostic data in epithelial ovarian cancer patients. Serum and tissue samples from 45...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Huixia, Hu, Hong, Yang, Zhihong, Li, Shaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145793/
https://www.ncbi.nlm.nih.gov/pubmed/37115089
http://dx.doi.org/10.1097/MD.0000000000033515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145793/
https://www.ncbi.nlm.nih.gov/pubmed/37115089
http://dx.doi.org/10.1097/MD.0000000000033515

Ejemplares similares